These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8849247

  • 1. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
    Jacobs RF, Kaplan SL, Schutze GE, Dajani AS, Leggiadro RJ, Rim CS, Puri SK.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):895-8. PubMed ID: 8849247
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
    Tan TQ, Schutze GE, Mason EO, Kaplan SL.
    Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
    [Abstract] [Full Text] [Related]

  • 3. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW, Aldridge KE, Gelfand MS.
    Diagn Microbiol Infect Dis; 1995 May; 22(1-2):35-42. PubMed ID: 7587048
    [Abstract] [Full Text] [Related]

  • 4. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
    Olivier C, Cohen R, Begué P, Floret D.
    Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
    [No Abstract] [Full Text] [Related]

  • 5. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
    Kaplan SL, Mason EO, Barson WJ, Tan TQ, Schutze GE, Bradley JS, Givner LB, Kim KS, Yogev R, Wald ER.
    Pediatr Infect Dis J; 2001 Apr; 20(4):392-6. PubMed ID: 11332663
    [Abstract] [Full Text] [Related]

  • 6. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
    Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA.
    J Clin Microbiol; 2002 Feb; 40(2):669-74. PubMed ID: 11825993
    [Abstract] [Full Text] [Related]

  • 7. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
    Chesney PJ, Davis Y, English BK, Wang WC.
    Pediatr Infect Dis J; 1995 Nov; 14(11):1013-5. PubMed ID: 8584345
    [No Abstract] [Full Text] [Related]

  • 8. Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate.
    Flórez C, Silva G, Martín E.
    Pediatr Infect Dis J; 1996 Aug; 15(8):723-4. PubMed ID: 8858688
    [No Abstract] [Full Text] [Related]

  • 9. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
    Michaus ML, Pérez-Díaz L, de Pablos M, Lezaun MJ, López-Bayón J.
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
    [No Abstract] [Full Text] [Related]

  • 10. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG, Erwin ME, Jones RN.
    Diagn Microbiol Infect Dis; 1995 May; 22(1-2):119-23. PubMed ID: 7587024
    [Abstract] [Full Text] [Related]

  • 11. Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae.
    Guibert M, Chahime H, Petit J, Odièvre M, Labrune P.
    Acta Paediatr; 1995 Jul; 84(7):831-3. PubMed ID: 7549311
    [Abstract] [Full Text] [Related]

  • 12. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins.
    Viladrich PF, Cabellos C, Pallares R, Tubau F, Martínez-Lacasa J, Liñares J, Gudiol F.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):218-20. PubMed ID: 8787909
    [Abstract] [Full Text] [Related]

  • 13. Criteria for testing the susceptibility of Streptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 microgram or 30 micrograms cefotaxime disks.
    Barry AL, Brown SD, Novick WJ.
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):724-6. PubMed ID: 8565996
    [Abstract] [Full Text] [Related]

  • 14. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
    Murphy ME, Powell E, Courter J, Mortensen JE.
    BMC Infect Dis; 2021 Jul 13; 21(1):679. PubMed ID: 34256734
    [Abstract] [Full Text] [Related]

  • 15. Increasing incidence of penicillin- and cefotaxime-resistant Streptococcus pneumoniae causing meningitis in India: Time for revision of treatment guidelines?
    Verghese VP, Veeraraghavan B, Jayaraman R, Varghese R, Neeravi A, Jayaraman Y, Thomas K, Mehendale SM.
    Indian J Med Microbiol; 2017 Jul 13; 35(2):228-236. PubMed ID: 28681811
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
    Fuchs PC, Barry AL, Brown SD.
    Diagn Microbiol Infect Dis; 2000 Aug 13; 37(4):265-9. PubMed ID: 10974578
    [Abstract] [Full Text] [Related]

  • 17. Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001).
    Jones RN, Mutnick AH, Varnam DJ.
    J Clin Microbiol; 2002 Nov 13; 40(11):4332-3. PubMed ID: 12409423
    [Abstract] [Full Text] [Related]

  • 18. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
    Buckingham SC, Brown SP, Joaquin VH.
    J Pediatr; 1998 Jan 13; 132(1):174-6. PubMed ID: 9470026
    [Abstract] [Full Text] [Related]

  • 19. Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
    Cabellos C, Guillem L, Pelegrin I, Tubau F, Ardanuy C, Gudiol F, Ariza J, Viladrich PF.
    Antimicrob Agents Chemother; 2022 Dec 20; 66(12):e0082022. PubMed ID: 36326246
    [Abstract] [Full Text] [Related]

  • 20. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.
    Friedland IR, Shelton S, Paris M, Rinderknecht S, Ehrett S, Krisher K, McCracken GH.
    Pediatr Infect Dis J; 1993 Mar 20; 12(3):196-200. PubMed ID: 8451095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.